164 related articles for article (PubMed ID: 8695987)
1. Outcome of idiopathic membranoproliferative glomerulonephritis in children. Arbeitsgemeinschaft Pädiatrische Nephrologie.
Schwertz R; de Jong R; Gretz N; Kirschfink M; Anders D; Schärer K
Acta Paediatr; 1996 Mar; 85(3):308-12. PubMed ID: 8695987
[TBL] [Abstract][Full Text] [Related]
2. Membranoproliferative glomerulonephritis type III: association of glomerular deposits with circulating nephritic factor-stabilized convertase.
West CD; McAdams AJ
Am J Kidney Dis; 1998 Jul; 32(1):56-63. PubMed ID: 9669425
[TBL] [Abstract][Full Text] [Related]
3. Glomerular paramesangial deposits: association with hypocomplementemia in membranoproliferative glomerulonephritis types I and III.
West CD; McAdams AJ
Am J Kidney Dis; 1998 Mar; 31(3):427-34. PubMed ID: 9506679
[TBL] [Abstract][Full Text] [Related]
4. Complement analysis in children with idiopathic membranoproliferative glomerulonephritis: a long-term follow-up.
Schwertz R; Rother U; Anders D; Gretz N; Schärer K; Kirschfink M
Pediatr Allergy Immunol; 2001 Jun; 12(3):166-72. PubMed ID: 11473682
[TBL] [Abstract][Full Text] [Related]
5. Long-term clinical and morphological evaluation of primary membranoproliferative glomerulonephritis.
Wu MJ; Shu KH; Chan LP; Lu YS; Cheng CH; Sheu SS; Hsu YH; Lian JD
Zhonghua Yi Xue Za Zhi (Taipei); 1996 Jan; 57(1):34-41. PubMed ID: 8820034
[TBL] [Abstract][Full Text] [Related]
6. C3 Glomerulopathy and Related Disorders in Children: Etiology-Phenotype Correlation and Outcomes.
Wong EKS; Marchbank KJ; Lomax-Browne H; Pappworth IY; Denton H; Cooke K; Ward S; McLoughlin AC; Richardson G; Wilson V; Harris CL; Morgan BP; Hakobyan S; McAlinden P; Gale DP; Maxwell H; Christian M; Malcomson R; Goodship THJ; Marks SD; Pickering MC; Kavanagh D; Cook HT; Johnson SA;
Clin J Am Soc Nephrol; 2021 Nov; 16(11):1639-1651. PubMed ID: 34551983
[TBL] [Abstract][Full Text] [Related]
7. Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.
Servais A; Frémeaux-Bacchi V; Lequintrec M; Salomon R; Blouin J; Knebelmann B; Grünfeld JP; Lesavre P; Noël LH; Fakhouri F
J Med Genet; 2007 Mar; 44(3):193-9. PubMed ID: 17018561
[TBL] [Abstract][Full Text] [Related]
8. [Familial membranoproliferative glomerulonephritis].
Bogdanović RM; Dimitrjević JZ; Nikolić VN; Ognjanović MV; Rodić BD; Slavković BV
Srp Arh Celok Lek; 1999; 127(5-6):163-71. PubMed ID: 10500423
[TBL] [Abstract][Full Text] [Related]
9. Occurrence of C3 nephritic factor and C4 nephritic factor in membranoproliferative glomerulonephritis (MPGN).
Ohi H; Yasugi T
Clin Exp Immunol; 1994 Feb; 95(2):316-21. PubMed ID: 8306508
[TBL] [Abstract][Full Text] [Related]
10. Membranoproliferative glomerulonephritis.
Alchi B; Jayne D
Pediatr Nephrol; 2010 Aug; 25(8):1409-18. PubMed ID: 19908070
[TBL] [Abstract][Full Text] [Related]
11. Idiopathic mesangiocapillary glomerulonephritis. Comparison of types I and II in children and adults and long-term prognosis.
Cameron JS; Turner DR; Heaton J; Williams DG; Ogg CS; Chantler C; Haycock GB; Hicks J
Am J Med; 1983 Feb; 74(2):175-92. PubMed ID: 6337487
[TBL] [Abstract][Full Text] [Related]
12. Dense intramembranous deposit disease: a clinical comparison of histological subtypes.
Kashtan CE; Burke B; Burch G; Gustav Fisker S; Kim Y
Clin Nephrol; 1990 Jan; 33(1):1-6. PubMed ID: 2302866
[TBL] [Abstract][Full Text] [Related]
13. Crescentic glomerulonephritis developing in the course of idiopathic membranoproliferative glomerulonephritis.
Sharma A; Gupta R; Lal C; Agarwal SK; Dinda AK
Saudi J Kidney Dis Transpl; 2013 Mar; 24(2):333-7. PubMed ID: 23538361
[TBL] [Abstract][Full Text] [Related]
14. Membranoproliferative glomerulonephritis with C3NeF and genetic complement dysregulation.
Leroy V; Fremeaux-Bacchi V; Peuchmaur M; Baudouin V; Deschênes G; Macher MA; Loirat C
Pediatr Nephrol; 2011 Mar; 26(3):419-24. PubMed ID: 21188423
[TBL] [Abstract][Full Text] [Related]
15. Management of membranoproliferative glomerulonephritis type II with plasmapheresis.
Kurtz KA; Schlueter AJ
J Clin Apher; 2002; 17(3):135-7. PubMed ID: 12378549
[TBL] [Abstract][Full Text] [Related]
16. Discordant renal histopathologic findings and complement profiles in membranoproliferative glomerulonephritis type III.
Meyers KE; Strife CF; Witzleben C; Kaplan BS
Am J Kidney Dis; 1996 Dec; 28(6):804-10. PubMed ID: 8957031
[TBL] [Abstract][Full Text] [Related]
17. Membranoproliferative glomerulonephritis (MPGN type I) and dense deposit disease (DDD) in children.
Davis AE; Schneeberger EE; Grupe WE; McCluskey RT
Clin Nephrol; 1978 May; 9(5):184-93. PubMed ID: 657595
[TBL] [Abstract][Full Text] [Related]
18. Comparison of pulse and oral steroid in childhood membranoproliferative glomerulonephritis.
Bahat E; Akkaya BK; Akman S; Karpuzoglu G; Guven AG
J Nephrol; 2007; 20(2):234-45. PubMed ID: 17514629
[TBL] [Abstract][Full Text] [Related]
19. C3 nephritic factor and C4 nephritic factor in the serum of two patients with hypocomplementaemic membranoproliferative glomerulonephritis.
Tanuma Y; Ohi H; Watanabe S; Seki M; Hatano M
Clin Exp Immunol; 1989 Apr; 76(1):82-5. PubMed ID: 2736802
[TBL] [Abstract][Full Text] [Related]
20. Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex-Mediated Membranoproliferative GN.
Iatropoulos P; Daina E; Curreri M; Piras R; Valoti E; Mele C; Bresin E; Gamba S; Alberti M; Breno M; Perna A; Bettoni S; Sabadini E; Murer L; Vivarelli M; Noris M; Remuzzi G; ;
J Am Soc Nephrol; 2018 Jan; 29(1):283-294. PubMed ID: 29030465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
